Search results for "mRNA platform concerns"

Witness Testimony Keywords from Transcript virology expertise, viral evolution theory, mRNA platform concerns, spike protein toxicity, lipid nanoparticle delivery, biodistribution issues, immune imprinting One Line Summary Virologist presents concerns about mRNA vaccine platform design, regulatory approval Couey, a biomedical scientist with expertise in virology and molecular genetics, testified regarding concerns He expressed concern about immune imprinting, repeated booster administration, and the impact of widespread

Witness Testimony Keywords from Transcript mRNA platform history, lipid nanoparticle inflammation, spike transcripts, GMP compliance concerns, biodistribution findings, endocrine system effects, immune suppression concerns, informed consent ethics, fifth-generation warfare concept, psyops deployment allegation, messaging He stated that he initially viewed COVID-19 genetic vaccines with concern because they encode the SARS-CoV Malone raised concerns about manufacturing quality, alleging evidence of plasmid DNA contamination, truncated

flags, conditional marketing authorization, gene therapy classification dispute, batch variability concerns November 2023 Main Topic Regulatory classification, manufacturing quality control, and safety assessment concerns Gutschi described concerns identified in European Medicines Agency (EMA) review documents, including standards used for large-scale commercial batches differed from those used in clinical trials and expressed concern characterized the regulatory review process as insufficiently rigorous given the novelty and complexity of the platform

pathway activation, kinase pathway dysregulation, adverse event mechanistic theory, genomic integration concern One Line Summary UBC biomedical scientist analyzes spike protein signaling effects and raises concerns about off-target molecular consequences of mRNA vaccines. He raised concerns regarding variability in mRNA translation levels, persistence of spike protein expression comprehensive molecular pharmacology and long-term safety testing are typically required for novel biologic platforms

COVID-19 vaccines based on spike protein interaction with the renin-angiotensin system and concerns regarding vaccine platform safety and immunological consequences. He also raised concerns about immune system dysregulation, including potential impairment of innate and Regarding mRNA vaccine technology, Dr. Sabatier expressed concerns about lipid nanoparticle biodistribution, pseudouridine-modified mRNA stability

Witness Testimony Keywords from Transcript mRNA vaccine regulation, gene therapy definition, EMA exclusion pharmacokinetics requirement, lipid nanoparticle toxicity, spike protein persistence, transplacental passage concern One Line Summary A French pharmacist-biologist argues that mRNA COVID-19 vaccines meet definitions of platforms, which involve injection of synthetic genetic material directing host cells to produce spike unusually compressed, with overlapping phases and limited dose-optimization studies, and referenced concerns

platform critique, immune suppression theory, blood clotting concern, chemotherapy resistance claim, William Makis testified that mRNA vaccines are linked to sudden deaths, aggressive cancers, and immune suppression, and that physicians raising concerns face regulatory retaliation. He further testified that physicians who raised concerns about vaccine safety, including himself, faced He expressed concern about ongoing booster campaigns and called for immediate cessation of mRNA vaccine

Keywords from Transcript neurodegenerative disease research, spike protein toxicity, blood-brain barrier concerns concerns, adverse event signals Included in the Report: Dr. One Line Summary UBC neuroscientist raises concerns about spike protein neurotoxicity, biodistribution , and potential long-term neurological effects of mRNA vaccines. deployment and expressed concern that safety signals may not have been fully explored prior to mass

4.7.1 mRNA Vaccines, Public Health, and Safety Concerns 4.7 mRNA Vaccines, Public Health, and Safety Jessica Rose during the NCI Vancouver Hearings expand on these concerns, with a focus on mRNA vaccine Jessica Rose, raised critical concerns about the safety of mRNA vaccines, particularly for vulnerable Concerns About “Shedding” Following vaccination, viral mRNA or mRNA fragments have been shown to occur There is also concern that the new technology of self replicating mRNA vaccines may lead to increased

Witness Testimony Keywords from Transcript Pfizer documents, mRNA platform, lipid nanoparticles, clinical regulatory capture, FDA oversight, spike protein, data transparency, batch contamination, fertility concerns One Line Summary Radiologist analyzes Pfizer trial data and post-marketing reports, raising concerns He also raised concerns about reported deaths during clinical trials and the classification and reporting Flowers further addressed issues related to the mRNA lipid nanoparticle platform, including biodistribution

Witness Testimony Keywords from Transcript mRNA integrity variation, spike protein isoforms, translation persistence months, nuclear entry concern, reverse transcription potential, dosage inconsistency, antibody protein heterogeneity raise safety, immunological, and policy concerns. He expressed concern about biodistribution studies indicating mRNA presence in multiple organs, including Beyond molecular analysis, Linard raised concerns about public health definitions and policy, including

5.7.1 mRNA Vaccines, Public Health, and Safety Concerns 5.7 Health and Medical Safety 5.7.1 mRNA Vaccines , Public Health, and Safety Concerns Recommendations Suspend mRNA Vaccine Roll-out: Implement an immediate moratorium on mRNA vaccines until independent safety verification is conducted. 2. Support Research and Accountability: Fund long-term studies on the effects of mRNA vaccines.